Sigilon Therapeutics, Inc. Gross Profit 2021-2023 | SGTX
Sigilon Therapeutics, Inc. gross profit from 2021 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Sigilon Therapeutics, Inc. Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2022 | $13 |
| 2021 | $10 |
| 2020 | $13 |
| 2019 | $14 |
| Sigilon Therapeutics, Inc. Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2023-06-30 | $6 |
| 2023-03-31 | $5 |
| 2022-12-31 | $3 |
| 2022-09-30 | $4 |
| 2022-06-30 | $3 |
| 2022-03-31 | $3 |
| 2021-12-31 | $2 |
| 2021-09-30 | $2 |
| 2021-06-30 | $3 |
| 2021-03-31 | $3 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $2 |
| 2020-03-31 | $3 |
